The largest database of trusted experimental protocols

Anti c5b 9 antibody

Manufactured by Quidel
Sourced in United States

The Anti-C5b-9 antibody is a laboratory reagent designed to detect the presence of the C5b-9 complex, also known as the membrane attack complex (MAC). The C5b-9 complex is a key component of the complement system, which plays a crucial role in the immune response. The Anti-C5b-9 antibody can be used to analyze and quantify the levels of this complex in various biological samples, providing researchers and scientists with a tool for studying the complement system and its involvement in different physiological and pathological processes.

Automatically generated - may contain errors

4 protocols using anti c5b 9 antibody

1

Complement Inhibition by Borrelial Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitory capacity of borrelial proteins on the CP, LP or the AP was analysed by a microtiter-based approach as described previously59 (link). Briefly, microtiter plates were coated with either human IgM (30 ng/ml) (Merck, Darmstadt, Germany) for the CP, mannan (1 µg/ml) (Merck, Darmstadt, Germany) for the LP or LPS (100 ng/ml) (Hycult Biotech, Beutelsbach, Germany), for the AP at 4 °C overnight. Following blocking, NHS (1% for the CP, 2% for the LP, and 15% for the AP) pre-incubated with His6-tagged proteins (10 µg each or increasing concentrations thereof) were added to initiate complement activation. Formation of the MAC was detected by using an anti-C5b-9 antibody (1:500) (Quidel, Athens, USA) and antigen–antibody complexes were visualized by applying HRP-conjugated anti-mouse immunoglobulins (1:1000). The reactions were developed by adding o-phenylenediamine (Merck, Darmstadt, Germany) and measuring the absorbance at 490 nm.
+ Open protocol
+ Expand
2

Serological Analyses of Anti-Borrelia Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-immune human serum (NHS) collected from healthy blood donors was initially tested for the presence of anti-Borrelia IgM and IgG antibodies as previously described (29 (link)). Only sera considered to be negative were combined to form a serum pool. All complement components were purchased from Complement Technology (Tyler, TX, USA). Polyclonal anti-FH and anti-C3 antisera were obtained from Merck Biosciences (Bad Soden, Germany) and the neoepitope-specific monoclonal anti-C5b-9 antibody was purchased from Quidel (San Diego, CA, USA). Purification of FHL-1, FH fragments containing different CCP domains, and the anti-CCP1-4 antiserum has been described previously (39 (link)). The monoclonal antibody L41 1C11 was used to detect the borrelial FlaB protein (40 (link)). Proteinase K and trypsin were purchased from Merck (Darmstadt, Germany). For the detection of His-tagged proteins, a mouse anti-His antiserum was used (GE Healthcare, Munich, Germany), and all horseradish peroxidase-conjugated immunoglobulins were purchased from Dako (Hamburg, Germany).
+ Open protocol
+ Expand
3

Plasminogen Activation and Complement Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human serum (NHS) was collected from healthy blood donors as described previously50 (link). Human glu-plasminogen was purchased from Haematologic Technologies (Essex Junction, VT, USA) and urokinase plasminogen activator (uPA) (Merck, Darmstadt, Germany) were used for the activation of plasminogen to plasmin. The chromogenic substrate S-2251 (D-Val-Leu-Lys p-nitroanilide dihydrochloride) were from Sigma-Aldrich (Steinheim, Germany). Factor H, Factor B, C3b, and C5 were purchased from Complement Technology (Tyler, TX, USA). Polyclonal anti-plasminogen antibody was purchased from Acris Antibodies (Herford, Germany), and the monoclonal anti-plasminogen antibody (clone 10-V-1) was from Calbiochem, Merck, Darmstadt, Germany). The polyclonal anti-FH and anti-C3 antibody were obtained from Merck Biosciences (Bad Soden, Germany) and the polyclonal anti-C5, anti-Factor B antibody as well as the neoepitope-specific monoclonal anti-C5b-9 antibody was from Quidel (San Diego, CA, USA). The mouse anti-His antiserum was obtained from Novagen (Merck Darmstadt, Germany) and Qiagen (Hilden, Germany) and the horseradish peroxidase (HRP)-conjugated immunoglobulins were purchased from Dako (Hamburg, Germany).
+ Open protocol
+ Expand
4

Quantifying Complement Inhibition by Orthologs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibitory capacity of CihC/FbpC orthologs on the classical (CP) and alternative pathway (AP) was assessed by employing an ELISA-based approach as described previously (26 (link), 27 (link)). Microtiter plates were coated with either human IgM (30 ng/ml) (Merck, Darmstadt, Germany) for the CP and Zymosan A (10 µg/µl) (Merck, Darmstadt, Germany) for the AP at 4°C overnight. Following three wash steps with TBS containing 0.05% Triton X-100 (TBS-T), wells were blocked with PBS containing 0.05% Tween20 and 1% BSA for 1 h at RT. NHS (1% for the CP and 15% for the AP) was pre-incubated with increasing concentrations of His-tagged proteins for 15 min at 37°C before added to the wells to initiate complement activation. After washing with TBS-T, the anti-C5b-9 antibody (1:500) (Quidel, Athens, OH; USA) was added to determine assembly of the pore-forming membrane attack complex. Following incubation for 1 h at RT, wells were washed thoroughly with TBS-T and incubated with HRP-conjugated anti-mouse IgG (1:1000) at RT for 1 h. After adding o-phenylenediamine, the absorbance values were measured at 490 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!